A
Abraham Rivenson
Researcher at National Institutes of Health
Publications - 98
Citations - 6267
Abraham Rivenson is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Azoxymethane & Carcinogen. The author has an hindex of 40, co-authored 98 publications receiving 6153 citations. Previous affiliations of Abraham Rivenson include Dana Corporation.
Papers
More filters
Journal Article
Chemoprevention of Colon Carcinogenesis by Dietary Curcumin, a Naturally Occurring Plant Phenolic Compound
TL;DR: Investigation of the chemopreventive action of dietary curcumin on azoxymethane-induced colon carcinogenesis and also the modulating effect of this agent on the colonic mucosal and tumor phospholipase A2, phospholIPase C gamma 1, lipoxygenase, and cyclo oxygengenase activities in male F344 rats indicates that dietary administration ofCurcumin significantly inhibited incidence of colon adenocarcinomas.
Journal Article
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Chinthalapally V. Rao,Abraham Rivenson,Barbara Simi,Edith Zang,Gary J. Kelloff,Vernon E. Steele,Bandaru S. Reddy +6 more
TL;DR: Results indicate that dietary sulindac at 160 and 320 ppm levels inhibited the incidence of invasive and noninvasive adenocarcinomas of the colon and suppressed the colon tumor volume in a dose-dependent manner.
Journal ArticleDOI
Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats
TL;DR: Investigation of the chemopreventive effect of 40 and 80% maximum tolerated dose (MTD) levels of aspirin administered in the diet on azoxymethane-induced colon carcinogenesis in male F344 rats supports the epidemiologic evidence that ingestion of aspirin inhibits Colon carcinogenesis.
Journal Article
Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen
TL;DR: It is suggested that Bifidobacterium supplements in the diet inhibit IQ-induced colon and liver tumors and to a lesser extent mammary tumors in F344 rats.
Journal Article
Induction of Lung and Exocrine Pancreas Tumors in F344 Rats by Tobacco-specific and Areca-derived N-Nitrosamines
TL;DR: The observation of benign and malignant tumors of the lung and pancreas of rats treated with the tobacco-specific nitrosamines NNK and NNAL is discussed in respect to the causal association between cigarette smoking and cancer of the Lung and Pancreas.